New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congress
Neuro Central,
Pooled analysis of fremanezumab Phase 3 studies indicates a positive cardiovascular safety profile in adult patients Further…